Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Kindred Biosciences, Inc. (KIN)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15Dec-31-14Dec-31-13
   10-K10-K10-K10-K10-K10-K10-K10-K
Cash Flows from Operating Activities          
Net income (loss)  -21.8-61.4-49.7-30.9-22.5-27.1-27.1-4.2
   
Adjustments to reconcile net income (loss) to net cash from (used in) operating activities:          
    Stock-based compensation expense  7.67.46.35.23.64.24.40.9
    Depreciation and amortization expense  4.72.50.80.50.20.10.1 
    Gain on disposal of property and equipment  0.10.20.00.00.0   
    Amortization of discount on marketable securities  0.0-0.5-0.20.2    
    Amortization of debt discount of loan payable  0.30.1      
    Finished goods write off related to Dechra asset purchase  3.8       
    Changes in operating assets and liabilities:          
        Accounts receivable  0.40.0-0.9     
        Inventories  0.2-0.6-3.6     
        Prepaid expenses and other  -0.9-0.8-0.90.5-0.6-0.2-0.3-0.1
        Accounts payable  -1.21.80.31.3-0.70.0-0.30.7
        Accrued liabilities and accrued compensation  -3.0-5.02.81.41.00.11.31.2
            Net cash provided by (used in) operating activities  -9.9-56.3-45.0-21.9-18.8-22.8-21.9-1.6
   
Cash Flows from Investing Activities          
Purchases of investments  -75.7-125.0-25.1-70.1-72.0-102.2-145.2 
Sales of investments   3.00.84.9 3.09.0 
Maturities of investments  85.082.654.668.578.3129.448.0 
Purchases of property and equipment  -3.6-8.4-13.9-5.9-1.0-0.7-0.40.0
Proceeds from sale of property and equipment  0.10.00.2     
    Net cash provided by investing activities  5.8-47.816.6-2.75.329.4-88.60.0
   
Cash Flows from Financing Activities          
Exercises of stock options and purchase of ESPP shares  0.42.01.00.50.20.30.10.0
Payment of restricted stock tax liability on net settlement  -0.9-0.5-0.2     
Net proceeds from sale of common stock  0.243.149.252.2  58.154.9
    Net cash provided by (used in) financing activities  -0.363.849.952.70.20.358.266.0
    Net change in cash and cash equivalents  -4.4-40.321.528.1    
   
Supplemental disclosure of non-cash investing and financing activities:          
    Purchases of property and equipment included in accounts payable and accrued liabilities  0.11.36.20.30.70.3  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy